vylaneca

Precision medicine is driving massive capital into miniaturized tech. Recent microfluidics startup news highlights a surge in “organ-on-chip” funding and new EIC Accelerator grants, as firms like Moonlight AI and CellType secure rounds to scale next-gen diagnostic and drug discovery platforms globally.